- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1738EUR$2,000USD£1,513GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2424EUR$2,789USD£2,110GBP
- Report
- August 2025
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- December 2025
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- October 2025
- 150 Pages
Global
From €3346EUR$3,850USD£2,912GBP
€4215EUR$4,850USD£3,668GBP
- Report
- September 2025
- 110 Pages
Global
From €3500EUR$4,314USD£3,153GBP
- Report
- October 2025
- 160 Pages
Global
From €3433EUR$3,950USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 278 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- October 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 135 Pages
Global
From €15639EUR$17,995USD£13,611GBP
- Report
- January 2024
- 150 Pages
Global
From €5171EUR$5,950USD£4,501GBP
- Report
- August 2022
- 120 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- April 2024
- 115 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- March 2024
- 200 Pages
Global
From €3607EUR$4,150USD£3,139GBP
- Report
- December 2024
- 152 Pages
Global
From €3433EUR$3,950USD£2,988GBP
- Report
- December 2024
- 30 Pages
Global
From €2390EUR$2,750USD£2,080GBP
- Report
- December 2024
- 30 Pages
Global
From €2390EUR$2,750USD£2,080GBP
- Report
- December 2024
- 30 Pages
Global
From €2390EUR$2,750USD£2,080GBP

The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more